It’s that time of year again.

I’m speaking, of course, of the J.P. Morgan Healthcare Conference. Starting Monday, management teams from hundreds of biotech and pharma companies will file into the Westin St. Francis Hotel on the western side of San Francisco’s Union Square. Over four days, these executives will stride up to podiums in conference rooms large and small to pitch their company’s investment story to crowds of Wall Street investors sitting in uncomfortably close quarters.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy